Funding Details
- Awarder
- RSS - feed.businesswire.com
- Date Award
- August 07, 2024
- Vertical
- Medical Devices
- Funding URL
- View Funding Page
Company Info
- Traction
- The company has completed a successful European First in Human study, the TANDEM I study, demonstrating sustained reductions in tricuspid regurgitation and marked improvements in patients’ quality of life metrics.
- Company Description
- CroíValve is a clinical stage medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation. The DUO™ System is designed to restore valve function while leaving the patient’s right heart and native valve apparatus untouched through an innovative anchoring mechanism.
- Market
- Cardiology
- Location
-
Ireland
- Coinvestors
- MedTech & Irrus Syndicates, Ascentifi, Furthr, Broadview Ventures, Atlantic Bridge University Fund, Enterprise Ireland, Elkstone, SOSV, IAG Capital Partners
Links